Ryman Healthcare Limited (RYHTY)

PNK: RYHTY · Real-Time Price · USD

7.55

0.25 (3.42%)

At close: Apr 22, 2025, 11:12 AM

Ryman Healthcare Income Statement

Financials in NZD. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018	Sep 30, 2017	Mar 31, 2017	Sep 30, 2016	Mar 31, 2016	Sep 30, 2015
Revenue	365.87M	316.67M	290.18M	269.93M	258.2M	245.56M	231.87M	220.54M	215.1M	207.01M	194.82M	186.98M	177.12M	164.97M	150.2M	138.53M	133.99M	126.37M
Cost of Revenue	359.03M	319.04M	291.73M	288.14M	258.7M	243.23M	226.57M	215.3M	195.38M	182.48M	149.02M	152.53M	135.96M	130.51M	118.1M	107.48M	103.64M	99.43M
Gross Profit	6.84M	-2.37M	-1.55M	-18.21M	-506K	2.33M	5.3M	5.24M	19.72M	24.53M	45.81M	34.45M	41.17M	34.47M	32.1M	31.06M	30.35M	26.93M
Operating Income	-10.77M	-2.37M	-1.55M	-18.21M	-506K	2.33M	5.3M	5.24M	19.72M	24.53M	31.73M	23.2M	28.84M	24.64M	24.3M	23.93M	22.98M	20.55M
Interest Income	1.05M	1.27M	1.78M	364K	15.41M	42K	11K	92K	317K	230K	9.68M	8.75M	8.29M	7.84M	5.15M	5.06M	4.36M	4.46M
Pretax Income	-288.36M	143.44M	-11.11M	217.3M	447.56M	274.52M	198M	212.5M	-24.58M	195.72M	159.52M	169.89M	185.29M	203.57M	168.31M	194.68M	173.91M	135.42M
Net Income	-181.91M	186.69M	63.85M	193.99M	411.41M	281.47M	210.66M	212.4M	76.43M	188.28M	156.45M	169.53M	185.59M	202.63M	169.69M	187.01M	172.84M	132.58M
Selling & General & Admin	231.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.2M	n/a	1.58M	n/a	n/a	n/a	1.1M	n/a
Research & Development	16.07M	n/a	11.74M	n/a	5.11M	n/a	5.14M	n/a	3.61M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	247.63M	135.03M	66.87M	227.57M	442.9M	267.29M	183.96M	185.41M	50.44M	166.26M	123.4M	144.19M	152.41M	176.94M	141.35M	168.68M	147.92M	112.94M
Interest Expense	28.94M	21.7M	186.02M	19.36M	15.41M	15.25M	9.78M	9.59M	9.75M	9.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	606.66M	319.04M	291.73M	288.14M	258.7M	243.23M	226.57M	215.3M	195.38M	182.48M	272.41M	296.72M	288.37M	307.45M	259.45M	276.16M	251.56M	212.38M
Income Tax Expense	106.45M	-43.25M	-74.96M	23.32M	36.15M	-6.94M	-12.66M	101K	-101M	7.44M	3.07M	359K	298K	938K	1.38M	7.68M	1.07M	2.83M
Shares Outstanding (Basic)	137.53M	137.53M	114.63M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	100M	100M	100M	100M	100M	100M	100M	100M
Shares Outstanding (Diluted)	137.53M	137.53M	114.63M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	100M	100M	100M	100M	100M	100M	100M	100M
EPS (Basic)	-1.3	1.35	0.55	1.85	3.90	2.65	2.00	2.00	0.70	1.75	1.55	1.70	1.85	2.05	1.70	1.85	1.75	1.35
EPS (Diluted)	-1.3	1.35	0.55	1.85	3.90	2.65	2.00	2.00	0.70	1.75	1.55	1.70	1.85	2.05	1.70	1.85	1.75	1.35
EBITDA	-11.14M	23.82M	22.05M	4.79M	17.34M	20.18M	22.01M	35.37M	34.59M	38.28M	41.01M	34.45M	38.28M	34.47M	32.1M	31.06M	29.25M	26.93M
EBIT	-259.42M	165.14M	174.91M	236.66M	462.97M	289.77M	207.77M	222.09M	-14.82M	205.28M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	-364K	26.19M	23.6M	23M	17.84M	17.85M	16.71M	15.66M	14.87M	13.75M	9.27M	11.25M	9.44M	9.83M	7.8M	7.13M	6.27M	6.38M